Abstract
Abstract Background Neurofilament light chain (NFL) is a biomarker for neuroaxonal damage and glial fibrillary acidic protein (GFAP) for reactive astrocytosis. Both processes occur in cerebral amyloid angiopathy (CAA), but studies investigating the potential of NFL and GFAP as markers for CAA are lacking. We aimed to investigate NFL and GFAP as biomarkers for neuroaxonal damage and astrocytosis in CAA. Methods For this cross-sectional study serum and cerebrospinal fluid (CSF) samples were collected between 2010 and 2020 from controls, (pre)symptomatic Dutch-type hereditary (D-CAA) mutation-carriers and participants with sporadic CAA (sCAA) from two prospective CAA studies at two University hospitals in the Netherlands. NFL and GFAP levels were measured with Simoa-assays. The association between NFL and GFAP levels and age, cognitive performance (MoCA), CAA-related MRI markers (CAA-CSVD-burden) and Aβ40 and Aβ42 levels in CSF were assessed with linear regression adjusted for confounders. The control group was divided in age < 55 and ≥55 years to match the specific groups. Results We included 187 participants: 28 presymptomatic D-CAA mutation-carriers (mean age 40 years), 29 symptomatic D-CAA participants (mean age 58 years), 59 sCAA participants (mean age 72 years), 33 controls < 55 years (mean age 42 years) and 38 controls ≥ 55 years (mean age 65 years). In presymptomatic D-CAA, only GFAP in CSF (7.7*10 3 pg/mL vs. 4.4*10 3 pg/mL in controls; P <.001) was increased compared to controls. In symptomatic D-CAA, both serum (NFL:26.2pg/mL vs. 12.5pg/mL; P =0.008, GFAP:130.8pg/mL vs. 123.4pg/mL; P =0.027) and CSF (NFL:16.8*10 2 pg/mL vs. 7.8*10 2 pg/mL; P =0.01 and GFAP:11.4*10 3 pg/mL vs. 7.5*10 3 pg/mL; P <.001) levels were higher than in controls and serum levels (NFL:26.2pg/mL vs. 6.7pg/mL; P =0.05 and GFAP:130.8pg/mL vs. 66.0pg/mL; P =0.004) were higher than in pre-symptomatic D-CAA. In sCAA, only NFL levels were increased compared to controls in both serum (25.6pg/mL vs. 12.5pg/mL; P =0.005) and CSF (20.0*10 2 pg/mL vs 7.8*10 2 pg/mL; P =0.008). All levels correlated with age. Serum NFL correlated with MoCA ( P =0.008) and CAA-CSVD score ( P <.001). NFL and GFAP in CSF correlated with Aβ42 levels ( P =0.01/0.02). Conclusions GFAP level in CSF is an early biomarker for CAA and is increased years before symptom onset. NFL and GFAP levels in serum and CSF are biomarkers for advanced CAA.